AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 82 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | -66.7% | 35,050 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $6,000 | -62.5% | 35,050 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $16,000 | -20.0% | 35,050 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $20,000 | -65.5% | 35,050 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $58,000 | -1.7% | 35,050 | 0.0% | 0.01% | -33.3% |
| Q2 2021 | $59,000 | 0.0% | 35,050 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $59,000 | +5.4% | 35,050 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $56,000 | +64.7% | 35,050 | 0.0% | 0.01% | +50.0% |
| Q3 2020 | $34,000 | +54.5% | 35,050 | 0.0% | 0.01% | +33.3% |
| Q2 2020 | $22,000 | +46.7% | 35,050 | 0.0% | 0.01% | +50.0% |
| Q1 2020 | $15,000 | -25.0% | 35,050 | 0.0% | 0.00% | -20.0% |
| Q4 2019 | $20,000 | +53.8% | 35,050 | +39.9% | 0.01% | +66.7% |
| Q3 2019 | $13,000 | +30.0% | 25,050 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $10,000 | -28.6% | 25,050 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $14,000 | +40.0% | 25,050 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $10,000 | -23.1% | 25,050 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $13,000 | -74.5% | 25,050 | +8.2% | 0.00% | -76.9% |
| Q2 2018 | $51,000 | -35.4% | 23,150 | 0.0% | 0.01% | -38.1% |
| Q1 2018 | $79,000 | +6.8% | 23,150 | +27.5% | 0.02% | +16.7% |
| Q4 2017 | $74,000 | +572.7% | 18,150 | 0.0% | 0.02% | +500.0% |
| Q3 2017 | $11,000 | +22.2% | 18,150 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $9,000 | -43.8% | 18,150 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $16,000 | 0.0% | 18,150 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $16,000 | +23.1% | 18,150 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $13,000 | -43.5% | 18,150 | 0.0% | 0.00% | -33.3% |
| Q2 2016 | $23,000 | -37.8% | 18,150 | +9.9% | 0.01% | -45.5% |
| Q1 2016 | $37,000 | -36.2% | 16,520 | 0.0% | 0.01% | -35.3% |
| Q4 2015 | $58,000 | +20.8% | 16,520 | 0.0% | 0.02% | -19.0% |
| Q3 2015 | $48,000 | +23.1% | 16,520 | 0.0% | 0.02% | +5.0% |
| Q2 2015 | $39,000 | -68.5% | 16,520 | 0.0% | 0.02% | -65.5% |
| Q1 2015 | $124,000 | +117.5% | 16,520 | 0.0% | 0.06% | +544.4% |
| Q4 2014 | $57,000 | +16.3% | 16,520 | +17.8% | 0.01% | 0.0% |
| Q3 2014 | $49,000 | -46.7% | 14,020 | +27.2% | 0.01% | -47.1% |
| Q2 2014 | $92,000 | -99.9% | 11,020 | +7.8% | 0.02% | -52.8% |
| Q1 2014 | $64,897,000 | – | 10,220 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shilanski & Associates, Inc. | 937,237 | $57,000 | 0.02% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $57,000 | 0.02% |
| CVA Family Office, LLC | 1,137,920 | $69,000 | 0.02% |
| Cypress Capital Management LLC (WY) | 140,925 | $9,000 | 0.01% |
| Helen Stephens Group, LLC | 117,222 | $7,000 | 0.01% |
| COURIER CAPITAL LLC | 540,056 | $33,000 | 0.00% |
| NORTHCAPE WEALTH MANAGEMENT, LLC | 98,000 | $6,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 10,000 | $1,000 | 0.00% |
| Western Wealth Management, LLC | 352,950 | $11,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 606,800 | $37,000 | 0.00% |